foxo4-dri p53 FOXO4 - an overview FOXO4-DRI Results: What to Expect

Given its effects on appetite, nutrition, and metabolism, use during these periods is not recommended

What are peptides and how do they work

Lower cagrilintide doses in combinations When combining, can reduce cagrilintide: 1.8mg cagrilintide + 2.4mg semaglutide: Still very effective (14-18% weight loss estimated) Better tolerated than both at 2.4mg Cost savings on cagrilintide Consider if GI-sensitive 1.2mg cagrilintide + 2.4mg semaglutide: Modest benefit from cagrilintide addition Minimal GI side effects from cagrilintide Semaglutide does heavy lifting May still achieve 12-15% total weight loss Testing approach: Start with standard doses (both 2.4mg) If intolerable, reduce cagrilintide first Maintain semaglutide at 2.4mg (well-tolerated, established) Find optimal cagrilintide dose for your tolerance Maintenance dosing after weight loss Strategies to sustain results long-term

It was an advisory judgment about whether the substances should be available for patient-specific compounding based on a clinical-need framework

Skipping days breaks the steady tissue-level signaling that drives results

Why no clinical drug development DSIP has not progressed through controlled clinical drug development, and the reasons map directly onto the issues discussed above: No identified receptor